EBNEO Commentary: De-MIST-ifying the 2-year outcomes of non-invasive surfactant therapy

Lucy Loft¹, Kristin N Ferguson^{2

3}, David G Tingay^{2

4}

Affiliations

¹ Neonatology, The Royal Women's Hospital, Melbourne, Victoria, Australia.
² Neonatal Research, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
³ Neonatology, Mercy Hospital for Women, Melbourne, Victoria, Australia.
⁴ Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.

Comment

Lucy Loft et al. Acta Paediatr. 2024 May.

. 2024 May;113(5):1121-1122.

doi: 10.1111/apa.17116. Epub 2024 Jan 25.

Lucy Loft¹, Kristin N Ferguson^{2

3}, David G Tingay^{2

4}

¹ Neonatology, The Royal Women's Hospital, Melbourne, Victoria, Australia.
² Neonatal Research, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
³ Neonatology, Mercy Hospital for Women, Melbourne, Victoria, Australia.
⁴ Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.

No abstract available

Keywords: brochopulmonary dysplasia; preterm; respiratory function; surfactant.

Comment on

Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.
Dargaville PA, Kamlin COF, Orsini F, Wang X, De Paoli AG, Kanmaz Kutman HG, Cetinkaya M, Kornhauser-Cerar L, Derrick M, Özkan H, Hulzebos CV, Schmölzer GM, Aiyappan A, Lemyre B, Kuo S, Rajadurai VS, O'Shea J, Biniwale M, Ramanathan R, Kushnir A, Bader D, Thomas MR, Chakraborty M, Buksh MJ, Bhatia R, Sullivan CL, Shinwell ES, Dyson A, Barker DP, Kugelman A, Donovan TJ, Goss KCW, Tauscher MK, Murthy V, Ali SKM, Clark HW, Soll RF, Johnson S, Cheong JLY, Carlin JB, Davis PG; OPTIMIST-A Trial Investigators. Dargaville PA, et al. JAMA. 2023 Sep 19;330(11):1054-1063. doi: 10.1001/jama.2023.15694. JAMA. 2023. PMID: 37695601 Free PMC article. Clinical Trial.

1. Dargaville PA, Kamlin COF, Orsini F, et al. Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: the OPTIMIST‐a randomized clinical trial. JAMA. 2021;326:2478‐2487.
1. Tingay DG, Wallace MJ, Bhatia R, et al. Surfactant before the first inflation at birth improves spatial distribution of ventilation and reduces lung injury in preterm lambs. J Appl Physiol. 2014;116:251‐258.
1. Thivierge E, Luu TM, Bourque CJ, et al. Pulmonary important outcomes after extremely preterm birth: parental perspectives. Acta Paediatr. 2023;112:970‐976.
1. Johnson S, Bountziouka V, Brocklehurst P, et al. Standardisation of the Parent Report of Children's Abilities‐Revised (PARCA‐R): a norm‐referenced assessment of cognitive and language development at age 2 years. Lancet Child Adolesc Health. 2019;3:705‐712.